Innoviva, Inc. (INVA)
21.35
+0.27
(+1.28%)
USD |
NASDAQ |
Sep 02, 16:00
21.35
0.00 (0.00%)
After-Hours: 20:00
Innoviva Research and Development Expense (Annual) : 30.60M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 30.60M |
| December 31, 2024 | 13.65M |
| December 31, 2023 | 33.92M |
| December 31, 2022 | 41.43M |
| December 31, 2021 | 0.576M |
| December 31, 2020 | 1.788M |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 1.355M |
| December 31, 2016 | 1.393M |
| December 31, 2015 | 2.619M |
| December 31, 2014 | 7.498M |
| December 31, 2013 | 125.18M |
| Date | Value |
|---|---|
| December 31, 2012 | 117.90M |
| December 31, 2011 | 103.57M |
| December 31, 2010 | 75.07M |
| December 31, 2009 | 77.52M |
| December 31, 2008 | 82.02M |
| December 31, 2007 | 155.25M |
| December 31, 2006 | 166.56M |
| December 31, 2005 | 134.68M |
| December 31, 2004 | 86.00M |
| December 31, 2003 | 61.70M |
| December 31, 2002 | 66.48M |
| December 31, 2001 | 53.77M |
| December 31, 2000 | 49.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Zevra Therapeutics, Inc. | 12.55M |
| Collegium Pharmaceutical, Inc. | 0.00 |
| CorMedix, Inc. | 19.33M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |